PTGS2 and cervical cancer: As shown in Figure 1 and Table 1, the IHC assay showed positive expression of COX-2 and iNOS in 49 of 87 (56.3%) and 46 of 87 (52.9%) of the cervical cancer tissue samples, respectively.